Inoviq Ltd (AU:IIQ) has released an update.
INOVIQ Ltd announces that its NEURO-NET technology successfully isolates brain-derived exosomes from Alzheimer’s patients, potentially revolutionizing the diagnosis and treatment of neurological diseases. The technology has outperformed competitors in identifying Alzheimer’s biomarkers and distinguishing between healthy and diseased states. These advancements may lead to the development of collaborative efforts to create new diagnostic tests for neurodegenerative diseases.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
